scispace - formally typeset
R

Ralph B. D'Agostino

Researcher at Wake Forest University

Publications -  1336
Citations -  250792

Ralph B. D'Agostino is an academic researcher from Wake Forest University. The author has contributed to research in topics: Framingham Heart Study & Framingham Risk Score. The author has an hindex of 226, co-authored 1287 publications receiving 229636 citations. Previous affiliations of Ralph B. D'Agostino include VA Boston Healthcare System & University of Illinois at Urbana–Champaign.

Papers
More filters
Journal ArticleDOI

Search for an optimal atherogenic lipid risk profile: from the Framingham Study.

TL;DR: In men, elevated LDL need not be treated aggressively if the total/HDL cholesterol ratio is low, and modest elevations of LDL may warrant more aggressive treatment if the ratio is high, while in women, the Ratio is also a good CHD predictor, but a combination of a high ratio accompanied by high LDL cholesterol may Warrant more aggressive therapy.
Journal ArticleDOI

Surrogate Markers of Insulin Resistance Are Associated with Consumption of Sugar-Sweetened Drinks and Fruit Juice in Middle and Older-Aged Adults

TL;DR: In these healthy adults, sugar-sweetened drink consumption appears to be unfavorably associated with surrogate measures reflecting hepatic more than peripheral insulin sensitivity, and studies of long-term beverage consumption using more direct measures of insulin sensitivity are clearly warranted.
Journal ArticleDOI

A randomized control trial of cardiac rehabilitation

TL;DR: Results indicate that implementing measures addressing the patient's general psycho-social adjustment to MI may improve existing programs and suggest that rehabilitation programs intervening on multiple levels (psychological, social, occupational, and physical) may best meet the needs of chronically ill cardiac patients.
Journal ArticleDOI

Alanine Aminotransferase and Directly Measured Insulin Sensitivity in a Multiethnic Cohort The Insulin Resistance Atherosclerosis Study

TL;DR: The findings suggest that the addition of alanine aminotransferase (ALT) to existing clinically based metabolic risk definitions is an inexpensive way to improve the identification of subjects with insulin resistance.
Journal ArticleDOI

Baldness and Coronary Heart Disease Rates in Men from the Framingham Study

TL;DR: The extent and progression of baldness and the aforementioned outcomes were assessed using a Cox proportional hazards model, adjusting for age and other known cardiovascular disease risk factors.